Document is current

Ebina, Kosuke https://orcid.org/0000-0002-2426-1024

Etani, Yuki https://orcid.org/0000-0001-5741-5969

Maeda, Yuichi https://orcid.org/0000-0002-6831-8205

Okita, Yasutaka https://orcid.org/0000-0003-3620-8412

Hirao, Makoto https://orcid.org/0000-0002-1408-7851

Yamamoto, Wataru https://orcid.org/0000-0002-0810-4221

Hashimoto, Motomu https://orcid.org/0000-0002-9241-060X

Murata, Koichi https://orcid.org/0000-0002-7896-3937

Hara, Ryota https://orcid.org/0000-0001-8000-3196

Nagai, Koji https://orcid.org/0000-0002-3183-4193

Hiramatsu, Yuri https://orcid.org/0000-0003-0944-7186

Son, Yonsu https://orcid.org/0000-0001-7244-7715

Amuro, Hideki https://orcid.org/0000-0002-7299-2884

Fujii, Takayuki https://orcid.org/0000-0002-6556-1226

Okano, Takaichi https://orcid.org/0000-0002-0873-5728

Ueda, Yo https://orcid.org/0000-0001-6065-8486

Katayama, Masaki https://orcid.org/0000-0002-0773-7238

Okano, Tadashi https://orcid.org/0000-0002-8849-9824

Tachibana, Shotaro https://orcid.org/0000-0001-7680-8071

Hayashi, Shinya https://orcid.org/0000-0003-4308-9845

Kumanogoh, Atsushi https://orcid.org/0000-0003-4749-7117

Okada, Seiji https://orcid.org/0000-0002-5107-8209

Nakata, Ken https://orcid.org/0000-0002-8964-4229

Funding for this research was provided by:

Janssen

Ono Pharmaceutical

AbbVie

Ayumi

UCB Japan

CAC

Sanofi

Eli Lilly and Company

Asahi-Kasei

Eisai

Teijin Healthcare

Taisho

Chugai Pharmaceutical

License valid from 2023-08-19